Exact Sciences (EXAS) PT Raised to $33 at Goldman Sachs, "Product Cycle Accelerates"
Get Alerts EXAS Hot Sheet
Price: $58.86 +1.99%
Rating Summary:
20 Buy, 9 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 8 | Down: 2 | New: 35
Rating Summary:
20 Buy, 9 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 8 | Down: 2 | New: 35
Join SI Premium – FREE
Goldman Sachs raised its price target on Exact Sciences (NASDAQ: EXAS) to $33.00 (from $21.00) while maintaining a Neutral rating.
Analyst Issac Ro raises EXAS PT on the heels of higher estimates. He models GMs of 64.8 percent for FY 2017 and anticipates profitability before the end of FY 2018.
FY 2017 EPS estimate rises from a loss of $1.49 to a loss of $1.30, FY 2018 EPS estimate rises from a loss of $0.82 to a loss of $0.61 and FY 2019 EPS estimate rises from $0.29 to $0.30.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Endava PLC (ADR) (DAVA) to Overweight 'on Favorable Risk/Reward + Takeaways from Investor Lunch'
- Guggenheim Starts Accenture plc (ACN) at Buy
- Guggenheim Starts EPAM Systems (EPAM) at Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT Change, Hot CommentsRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!